P&G stannous fluoride analysis suggested as industry-wide model by Plaque Subcommittee.
This article was originally published in The Tan Sheet
Executive Summary
P&G FLUORIDE ANALYSIS AS "MODUS OPERANDI" SUGGESTED BY PLAQUE SUBCMTE. for companies to follow in the quest to prove efficacy in fighting plaque, gingivitis and gingival bleeding. Procter & Gamble's analyses of the efficacy of stannous fluoride, presented at the Dec. 16-17 meeting of the Dental Product Panel Plaque Subcommittee, may serve as an "umbrella" model that, "while not definitive for every product," may provide "a general modus operandi" for other ingredients seeking to claim prevention and reduction of gingivitis, said subcommittee Chair Robert Genco, PhD, SUNY-Buffalo School of Medicine.
You may also be interested in...
Supplement GMP Warning Letters Make Modest Debut In 2010
Finalization of a settlement between the Federal Trade Commission and Rexall Sundown regarding unsupported cellulite treatment claims for the firm's Cellasene dietary supplement hinges upon approval of two related class action settlements pending in California and Florida, according to FTC
In Brief
Combe sells most of its OTC brands
People In Brief
Perrigo promotes in pricing, planning